Analysis of cellular events using CellCard™ system in cell-based high-content multiplexed assays

Expert Review of Molecular Diagnostics

Volumn 5, Issue 5, 2005, Pages 817-829

  Chen, Taosheng ^a   Hansen, George ^a   Beske, Oren ^b   Yates, Kristin ^c   Zhu, Yingjie ^a   Anthony, Monique ^a   Agler, Michele ^a   Banks, Martyn ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Vitra Bioscience Inc   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Assay performance; Cell based assays; CellCard System; Cytotoxicity; High content assays; High throughput screening; Imaging; Multiplexed assays

Indexed keywords

CASPASE 3;

BIOLUMINESCENCE; CELL ASSAY; CELL CULTURE; CELL TYPE; CELL VIABILITY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; REVIEW; SCREENING; TECHNOLOGY;

BIOLOGICAL ASSAY; CASPASE 3; CELL LINE, TUMOR; CELL PHYSIOLOGICAL PHENOMENA; CELL PHYSIOLOGY; CELL SURVIVAL; HUMANS;

EID: 25144491590     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.5.5.817     Document Type: Review

References (37)

1. Moore K, Rees S. Cell-based versus isolated target screening: how lucky do you feel? J. Biomol. Screen. 6(2), 69-74 (2001). Compares cell-based assays with biochemical assays.
2. Hertzberg RP, Pope AJ. High-throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4(4), 445-451 (2000).
3. Zaccolo MF, De Giorgi, Cho CY et al. A genetically encoded, fluorescent indicator for cyclic AMP in living cells. Nature Cell Biol. 2(1), 25-29 (2000).
4. Durick K, Negulescu P. Cellular biosensors for drug discovery. Biosens. Bioelectron. 16(7-8), 587-592 (2001).
5. Numann R, Negulescu PA. High-throughput screening strategies for cardiac ion channels. Trends Cardiovasc. Med. 11(2), 54-59 (2001).
6. Smart DJ, Jerman C, Gunthorpe MJ et al. Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur. J. Pharmacol. 417(1-2), 51-58 (2001).
7. Whiteaker KL, Gopalakrishnan SM, Groebe D et al. Validation of FLIPR membrane potential dye for high-throughput screening of potassium channel modulators. J. Biomol. Screen. 6(5), 305-312 (2001).
8. Baxter DF, Kirk M, Garcia AF et al. A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels. J. Biomol. Screen. 7(1), 79-85 (2002).
9. 2+ mobilization studies. Prostaglandins Leukot. Essent. Fatty Acids 68(1), 27-33 (2003).
10. Ding GJ, Fischer PA, Boltz RC et al. Characterization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α. Development and use of a high capacity fluorescence cytometric system. J. Biol. Chem. 273(44), 28897-28905 (1998).
11. Conway BR, Demarest KT. The use of biosensors to study GPCR function: applications for high-content screening. Recept. Channels 8(5-6), 331-341 (2002).
12. Ozkan M. Quantum dots and other nanoparticles: what can they offer to drug discovery? Drug Discov. Today 9(24), 1065-1071 (2004).
13. Mattheakis LC, Dias JM, Choi YJ et al. Optical coding of mammalian cells using semiconductor quantum dots. Anal. Biochem. 327, 200-208 (2004).
14. Kapur R. Fluorescence imaging and engineered biosensors: functional and activity-based sensing using high content screening. Ann. NY Acad. Sci. 961, 196-197 (2002).
15. Dove A. Screening for content-the evolution of high-throughput. Nature Biotechnol. 21(8), 859-864 (2003).
16. Honeysett JM. High-throughput microscopy in drug discovery. PharmaGenom. 3(8), 32-44 (2003).
17. Giuliano KA, Haskins JR, Taylor DL. Advances in high content screening for drug discovery. Assay Drug Dev. Technol. 1(4), 565-577 (2003).
18. Ziauddin J, Sabatini DM. Microarrays of cells expressing defined cDNAs. Nature 411(6833), 107-110 (2001).
19. Eickhoff H, Konthur Z, Lucking A et al. Protein array technology: the tool to bridge genomics and proteomics. Adv. Biochem. Eng. Biotechnol. 77, 103-112 (2002).
20. Wu RZ, Bailey SN, Sabatini DM. Cell-biological applications of transfected-cell microarrays. Trends Cell Biol. 12(10), 485-488 (2002).
21. Beske O, Goldbard S. High-thgoughput cell analysis using multiplexed array technologies. Drug Discov. Today 7(18), S131-S135 (2002). Discusses the concept and development of the CellCard™ System.
22. Beske O, Guo J, Bassoni D et al. A novel encoded particle technology that enables simultaneous interrogation of multiple cell types. J. Biomol. Screen. 9(3), 173-185 (2004). Reviews the current CellCard System and its applications in various assays.
23. Rose WC, Lee FY, Fairchild CR et al. Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor. Cancer Res. 15(61), 7507-7517 (2001).
24. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4(2), 67-73 (1999).
25. O'Brien MA, Daily WJ, Hesselberth PE et al. Homogeneous, bioluminescent protease assays: caspase-3 as a model. J. Biomol. Screen. 10(2), 137-148 (2005).
26. Yang XH, Edgerton S, Thor AD. Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. Int. J. Oncol. 26(6), 1675-1680 (2005).
27. Glese K, Kaufmann J, Pronk GJ, Klippel A. Unraveling novel intracellular pathways in cell-based assays. Drug Discov. Today 7, 179-186 (2002).
28. Riss T, Moravec R. Use of multiple assay end points to investigate the effects of incubation time, dose of toxin and plating density in cell-based cytotoxicity assays. Assay Drug Dev. Technol. 2, 51-62 (2004).
29. Braeckmans K, De Smedt SC, Leblans M, Pauwels R, Demeester J. Encoding microcarriers: present and future technologies. Nature Rev. Drug Disc. 1, 447-456 (2002).
30. Koch W. Technology platforms for pharmacogenomic diagnostic assays. Nature Rev. Drug Disc. 3, 749-761 (2004).
31. Martins TB, Pasi BM, Litwin VM, Hill HR. Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum. Clin. Diagn. Lab. Immunol. 11, 325-329 (2004).
32. Martins TB. Development of internal control for the Luminex instrument as part of a multiple seven-analyte viral respiratory antibody profile. Clin. Diagn. Lab. Immunol. 9, 41-45 (2002).
33. Joos TO, Stoll D, Templin M. Miniaturized multiplexed immunoassays. Curr. Opin. Chem. Biol. 6, 76-80 (2001).
34. Bhadriraju K, Chen C. Engineering cellular microenvironments to improve cell-based drug testing. Drug Discov. Today 7, 612-620 (2002).
35. Swedlow JR, Goldberg I, Brauner E, Sorger PK. Informatics and quantitative analysis in biological imaging. Science 300, 100-102 (2003).
36. Eils R, Anthale C. Computational imaging in cell biology. J. Cell Biol. 161, 477-481 (2003).
37. Gribbon P, Lyons R, Laflin P. Evaluating real-life high-throughput screening data. J. Biomol. Screen. 10(2), 99-107 (2005).